OWL

• Mission, Vision, Strategy, Business Lines
• OWL Technology
• Certifications
  - Reference Laboratory Certificate
  - ISO 9001
• Scientific and sales team
• Partners and collaborators
• Investors
• Company patents
• Scientific articles
• Careers

User Password

• Forgot your password?
• Request registry

Partners and collaborators

OWL has an extended network of partners and collaborators with scientific institutions, hospitals, biotechnology and pharmaceutical companies:

• 

  CIC bioGUNE

  The association between OWL and CIC bioGUNE is supporting the objective of CIC bioGUNE: promoting interactions between public research groups and commercial R+D laboratories.

  View web

• 

  CIC bioMAGUNE

  Owl collaborates with CIC bioMAGUNE on new research programs in the interface between chemistry, physics and biology, with particular emphasis on the properties and applications of molecular-level biological nanostructures.

  View web

• 

  Gregorio Marañón Hospital

  This hospital has remarkable technological facilities, along with an important educational area and research experience, and qualified and dedicated personnel. Adaptability to change and coordination with Social and Health Institutions are the most remarkable challenges. OWL is dynamically collaborating with the hepatologist Dr. Clemente in the identification of genomic signatures of hepatic pathologies, such as NASH, steatosis, cirrhosis or hepatitis.

  View web

• 

  UPV/EHU

  OWL collaborates with Basque Country University in the design and the implementation of the Master in Molecular Biology and Biomedicine. Some subjects related to Metabolomics were designed and are given by OWL experts. (Cellular and molecular basis of Liporegulation).

  View web

• 

  Clínic Hospital in Barcelona

  OWL has set up a collaboration with the Clinic Hospital in Barcelona to develop new diagnosis systems. Hospital Clínic de Barcelona is one of the best medical assistance centers in Spain and the first one in scientific production. It´s divided in services and institutions by medical specialities and provides outstanding patient-based quality assistance, first level biomedical investigation and top quality teaching dedication in order to bring out excellent professionals. It has the objective of providing society with humanized, state of the art medicine.

  View web

• 

  Foundation for the Applied Medical Research (FIMA) of the University of Navarra (UNAV)

  OWL collaborates with FIMA in /"Project NASH" studying the proteins that have been differentially translated during the development of non-alcoholic steatohepatitis (NASH). At present, this collaboration includes other diseases, such as Multiple Sclerosis.

  View web

• 

  Noraybio

  OWL and NorayBio are developing together products that will improve the MetilGenomics platform.

  View web

• 

  Príncipe de Astúrias Hospital in Alcalá de Henares

  OWL has established a collaboration with the Principe de Asturias Hospital in Alcala de Henares to centralize and handle the hepatic tissue and serum samples from patients diagnosed with liver diseases in different stages which would allow to validate the diagnostic markers and therapeutic drugs.

  View web

• 

  PROGENIKA Group (Progénika, Proteómika and Abyntek Biopharma)

  OWL and Progenika are collaborating together in projects related to the liver (NASH, steatosis) linked by a common goal: the identification and validation of diagnostic and prognostic biomarkers, as well as potential therapeutic targets.

  View web

• 

  Noscira

  Former Neuropharma, this company is part of the Zeltia Group. It is a biopharmaceutical company devoted to the research and development of innovative drugs for the treatment and prevention of diseases of the nervous system and it is currently developing two new products for the treatment of Alzheimer's disease. OWL collaborates with Noscira in a CENIT Project aiming to apply metabolomics technology to those two products.

  View web

• 

  Cross Road Biotech

  CRB is a venture-capital company focused on searching, selecting and investing in R+D developments for the creation and management of biotech companies in life science. CRB's mission is to drive the creation of a business framework, with high added value, through the transformation of the opportunities presented by scientific research in biotechnology, into profitable businesses. CRB is Founder Member and major shareholder of OWL.

  View web

• 

  Digna Biotech

  Digna Biotech is a biotechnological company dedicated to the development and exploitation of the research products generated by the Center of Applied Medical Research (CIMA) in Pamplona. OWL has reached an agreement with Digna Biotech to develop therapeutic and diagnostic applications for great prevalence diseases.

  View web

• 

  BIOEF

  The Basque Foundation for Health Innovation and Research (BIOEF, from the Basque Berrikuntza + Ikerketa + Osasuna Eusko Fundazioa), set up by the Department of Health of the Government of the Basque Country, is an instrument to support the health authorities of the Basque Country.Its mission is to promote innovation and research in the Basque Health Service, Osakidetza, to achieve continuous development and improvement in the capacity of the service to care for the health of the people in the region.

  View web

• 

  Fundación Clinic

  The Clinic Foundation's mission is to offer a portfolio of excellent services to the research and innovation communities that consolidate the organization as a national and international referent. The goal is to contribute to improving the health and quality of life of the population level through the competence, the skills, a responsible sustainable work and a scientific and social orientation.
  
  

  View web

• 

  Fundación Renal Iñígo Álvarez de Toledo ( FRIAT )

  View web

Back to top